US 9789162
Systemic and local ex vivo gene therapy of the skeleton
granted A61KA61K35/28A61K38/1858
Quick answer
US patent 9789162 (Systemic and local ex vivo gene therapy of the skeleton) held by The United States of America as represented by the Department of Veteran Affairs expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Department of Veteran Affairs
- Grant date
- Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K35/28, A61K38/1858, A61K47/548, A61K47/62